Therapeutic Controversies in Spondyloarthritis Nonsteroidal Anti-Inflammatory Drugs

被引：20
作者：
Poddubnyy, Denis [1 ]
van der Heijde, Desiree [2 ]
机构：
[1] Charite, Dept Med 1, D-12203 Berlin, Germany
[2] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands
来源：
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2012年 / 38卷 / 03期
关键词：
Spondyloarthritis; Ankylosing spondylitis; ASAS; Nonsteroidal anti-inflammatory drugs; Therapy; ACTIVE ANKYLOSING-SPONDYLITIS; RANDOMIZED CONTROLLED-TRIAL; OPEN-LABEL TRIAL; AXIAL SPONDYLOARTHRITIS; RADIOGRAPHIC PROGRESSION; ASAS/EULAR RECOMMENDATIONS; RHEUMATOID-ARTHRITIS; ASAS RECOMMENDATIONS; ULCER COMPLICATIONS; SPINAL MOBILITY;
D O I：
10.1016/j.rdc.2012.08.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Nonsteroidal anti-inflammatory drugs (NSAIDs) are considered a first-line therapy in patients with axial spondyloarthritis (axSpA), including ankylosing spondylitis. NSAIDs reduce pain and stiffness effectively in most patients, are able to reduce systemic and local inflammation, and can inhibit progression of structural damage in the spine. However, effective control of symptoms and retardation of radiographic progression often require continuous and long-term treatment, which raises safety concerns. This article discusses controversies related to the current role of NSAIDs in axSpA treatment, risks and benefits of this treatment, and current trends for individualized treatment.
引用
收藏
页码：601 / +
页数：12
相关论文
共 47 条
[41]   Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years [J].
van der Heijde, Desiree ;
Salonen, David ;
Weissman, Barbara N. ;
Landewe, Robert ;
Maksymowych, Walter P. ;
Kupper, Hartmut ;
Ballal, Shaila ;
Gibson, Eric ;
Wong, Robert .
ARTHRITIS RESEARCH & THERAPY, 2009, 11 (04)
[42]  
Vane J, 1998, JCR-J CLIN RHEUMATOL, V4, pS3
[43]   Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis -: A randomized clinical trial [J].
Wanders, A ;
van der Heijde, D ;
Landewé, R ;
Béhier, JKM ;
Calin, A ;
Olivieri, I ;
Zeidler, H ;
Dougados, M .
ARTHRITIS AND RHEUMATISM, 2005, 52 (06) :1756-1765
[44]   Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis:: can assessment of spinal mobility be a proxy for radiographic evaluation? [J].
Wanders, A ;
Landewé, R ;
Dougados, M ;
Mielants, H ;
van der Linden, S ;
van der Heijde, D .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (07) :988-994
[45]   Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib [J].
White, WB ;
Faich, G ;
Borer, JS ;
Makuch, RW .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (04) :411-418
[46]   Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair [J].
Zhang, XP ;
Schwarz, EM ;
Young, DA ;
Puzas, JE ;
Rosier, RN ;
O'Keefe, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (11) :1405-1415
[47]   Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis -: a population-based survey [J].
Zochling, Jane ;
Bohl-Buehler, Martin H. J. ;
Baraliakos, Xenofon ;
Feldtkeller, Ernst ;
Braun, Juergen .
CLINICAL RHEUMATOLOGY, 2006, 25 (06) :794-800
12345